Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 15;25(8):795-800.
doi: 10.1101/gad.2016211.

Autophagy-deficient mice develop multiple liver tumors

Affiliations

Autophagy-deficient mice develop multiple liver tumors

Akito Takamura et al. Genes Dev. .

Abstract

Autophagy is a major pathway for degradation of cytoplasmic proteins and organelles, and has been implicated in tumor suppression. Here, we report that mice with systemic mosaic deletion of Atg5 and liver-specific Atg7⁻/⁻ mice develop benign liver adenomas. These tumor cells originate autophagy-deficient hepatocytes and show mitochondrial swelling, p62 accumulation, and oxidative stress and genomic damage responses. The size of the Atg7⁻/⁻ liver tumors is reduced by simultaneous deletion of p62. These results suggest that autophagy is important for the suppression of spontaneous tumorigenesis through a cell-intrinsic mechanism, particularly in the liver, and that p62 accumulation contributes to tumor progression.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mosaic deletion of Atg5 causes multiple liver tumors. (A) Genotyping of Atg5flox/flox;CAG-Cre mouse organs by PCR at 1 mo. Positions of the Atg5 flox (undeleted) and recombinant (deleted) alleles are indicated. Atg5Δ/Δ mouse embryonic fibroblasts (MEFs) indicates Atg5flox/flox MEFs infected with the adenovirus vector coding Cre recombinase. (SM) Skeletal muscle. (B) Real-time quantitative PCR with the Atg5 flox allele-specific primers. Genomic DNA is extracted from various tissues of Atg5flox/flox;CAG-Cre mice and Atg5flox/flox mice at 1 mo (blue circles), 6 mo (red circles), and 12–19 mo (green circles) (n = 3). The relative DNA quantity of the Atg5 flox allele is normalized to that of Atg14. Ratio (percentage) of flox allele in Atg5flox/flox;CAG-Cre organs to that in Atg5flox/flox organs is shown. (C) Representative gross anatomy of Atg5flox/flox;CAG-Cre mice analyzed at 6 mo (n = 3), 9 mo (n = 6), and 18–19 mo (n = 9).
Figure 2.
Figure 2.
Histological findings of the liver in Atg5flox/flox;CAG-Cre mice. (A) Hematoxylin and eosin (H&E) staining of Atg5flox/flox;CAG-Cre (n = 2). Bar, 500 μm. (B) High-power-field images of H&E staining of the livers from Atg5flox/flox;CAG-Cre mice (n = 4) and an Atg5flox/+; CAG-Cre mouse (n = 4) at 19 mo. The arrow shows a necrotic hepatocyte observed in a Atg5flox/flox;CAG-Cre mouse liver at 19 mo. Bar, 20 μm. (C) Electron micrographs of Atg5flox/flox;CAG-Cre mouse hepatocytes (n = 2). (Right) Magnified image shows swollen mitochondria. Bars: left, 4 μm; right, 500 nm.
Figure 3.
Figure 3.
Liver tumors are derived from Atg5-deleted hepatocytes. (A) Genotyping of liver samples microdissected from the tumor and nontumor areas of 9-mo-old Atg5flox/flox;CAG-Cre mice. Positions of the Atg5 flox (undeleted) and recombinant (deleted) alleles are indicated. Atg5Δ/Δ MEFs indicate Atg5flox/flox MEFs infected with the adenovirus vector coding Cre recombinase. (B) Immunohistochemical staining for ubiquitin and p62 of the tumor and nontumor areas of Atg5flox/flox;CAG-Cre mouse livers. The graph shows the percentage of cells with ubiquitin- or p62-positive aggregates in the tumor (gray) and nontumor (white) areas. One-hundred hepatocytes in 10 tumor and nontumor areas (total 1000 cells for each) were analyzed at 9 mo. Data are mean ± SE values from four mice. (*) P < 0.01. Bars: 40 μm; insets, 10 μm.
Figure 4.
Figure 4.
Induction of the oxidative stress and DNA damage responses in Atg5flox/flox;CAG-Cre mouse livers. (A) Immunohistochemical analysis of the tumor and nontumor areas in Atg5flox/flox;CAG-Cre mouse livers at 19 mo for Ki-67 expression. n = 3. Bar, 50 μm. (B) 8-OHdG staining of the tumor and nontumor areas in the liver of Atg5flox/flox;CAG-Cre mice at 19 mo. White arrows indicate anti-8-OHdG antibody-positive nuclei (n = 3). Bar, 40 μm. (C) Phospho-histone H2A.X staining in the liver of Atg5flox/flox;CAG-Cre (n = 3) and Atg5flox/+;CAG-Cre (n = 3) mice at 19 mo. Black arrows indicate phospho-histone H2A.X-positive nuclei. Bars: 100 μm; insets, 10 μm.
Figure 5.
Figure 5.
Suppression of tumor progression in liver-specific ATG7-deficient mice by p62 deletion. (A) Representative gross anatomy of Atg7flox/flox;Alb-Cre mice analyzed at 12 mo (n = 11) and Atg7flox/flox;Alb-Cre; p62−/− mice analyzed at 12 mo (n = 4) and 18 mo (n = 3). Tumors are indicated by arrows. (B) Summary of tumor formation in Atg7flox/flox;Alb-Cre and Atg7flox/flox;Alb-Cre; p62−/− mice. (*) Small tumors (<5 mm).

References

    1. Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Øvervatn A, Stenmark H, Johansen T 2005. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603–614 - PMC - PubMed
    1. Cadet J, Douki T, Gasparutto D, Ravanat JL 2003. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res 531: 5–23 - PubMed
    1. Cecconi F, Levine B 2008. The role of autophagy in mammalian development: cell makeover rather than cell death. Dev Cell 15: 344–357 - PMC - PubMed
    1. Chen N, Debnath J 2010. Autophagy and tumorigenesis. FEBS Lett 584: 1427–1435 - PMC - PubMed
    1. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, et al. 2006. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51–64 - PMC - PubMed

Publication types

MeSH terms